deltatrials
Unknown EARLY_PHASE1 INTERVENTIONAL 2-arm NCT05251779

A Clinical Study on the Effects of Inhalation of Volatile Oil of Cang-Ai Via the Nose on Patients With Depression

Sponsor: Jieqiong Cui

Updated 6 times since 2022 Last updated: Oct 19, 2022 Started: Nov 1, 2022 Primary completion: Dec 1, 2022 Completion: Dec 1, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Depressive Disorder and Mental Disorder in Adolescence and is currently ongoing. Jieqiong Cui leads this study, which shows 6 recorded versions since 2022 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

~Mar 2022 – ~Sep 2022 · 6 months · monthly snapshotNot Yet Recruiting~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshot~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshotNot Yet Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – present · 20 months · monthly snapshotUnknown

Change History

6 versions recorded
  1. Nov 2024 — Present [monthly]

    Unknown EARLY_PHASE1

    Status: Not Yet RecruitingUnknown

  2. Sep 2024 — Nov 2024 [monthly]

    Not Yet Recruiting EARLY_PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Not Yet Recruiting EARLY_PHASE1

  4. Nov 2022 — Jul 2024 [monthly]

    Not Yet Recruiting EARLY_PHASE1

  5. Sep 2022 — Nov 2022 [monthly]

    Not Yet Recruiting EARLY_PHASE1

Show 1 earlier version
  1. Mar 2022 — Sep 2022 [monthly]

    Not Yet Recruiting EARLY_PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Jieqiong Cui
Data source: Yunnan University of Chinese Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.